RheaVita
About:
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products.
Website: https://www.rheavita.com
Twitter/X: rheavita
Top Investors: PMV, Novalis Biotechnology Incubation
Description:
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze-drying process step unit operations in a continuous production line with the constant infeed of products and the concomitant outfeed of the dried product. Its manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-market, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.
2.5M EUR
$1M to $10M
Zwijnaarde, Oost-Vlaanderen, Belgium
2018-01-01
info(AT)rheavita.com
Jos Corver, Thomas De Beer
11-50
2021-06-02
Private
© 2025 bioDAO.ai